Xinnan Zhang

Xinnan Zhang is an accomplished professional in the field of chemical development, currently serving as the Executive Director of Chemical Development at Nurix Therapeutics since January 2023. Prior experience includes roles as Sr. Director of Chemical Development at Kronos Bio, Inc. and Principia Biopharma, with a focus on overseeing drug substance CMC activities across multiple drug candidates. Zhang led API development and manufacturing at RELYPSA, where responsibilities included strategizing long-term API plans and ensuring cost-effective supply. Earlier experience includes positions at Symyx Technologies and National Starch and Chemical Co., with a strong foundation stemming from a PhD and Master of Science in Chemistry from the University of Michigan and a Bachelor's degree from Peking University.